News & Updates
Joselyn Rwebemera wins Sliver Medal/second place of over 1000 abstracts
Pranava Sinha, MD – a key partner of Dr. Craig Sable and Heart Healers International – has been awarded a grant through Children's National Hospital for a heart surgery mission trip to Uganda for this September.
This month our founder Dr. Craig Sable appeared on the Colony Group's podcast, 'Seeking the Extraordinary' with Michael Nathanson.
A new presidential advisory from the American Heart Association that includes Dr. Sable as an author, provides new insights into very rare, but serious adverse reactions to Penicillin in patients with rheumatic heart disease.
The paper, based on a registry of over 600 children in Uganda who had symptoms of RHD, is some of the most compelling data we’ve ever published that captures the extreme severity of RHD.
The paper provides a follow-up to previous studies published in 2017 and 2019 and tracks a significant disparity between CHD mortality in high income and low income countries.
Heart Healers International is proud to be a part of a new study about Rheumatic Heart Disease (RHD), published today in The New England Journal of Medicine. The study proves that penicillin works to prevent the progression of early echo detected RHD. RHD affects 40.5 million people globally and results in over 306,000 annual deaths
“We are excited to share an inspirational story about a medical team from the United States and Uganda who bonded together during this uncertain time to treat patients with heart disease and to continue building a sustainable heart surgery program in Uganda.”
In the News
“We know from previous studies that sub-Saharan Africa continues to have the highest numbers of people with rheumatic heart disease, and the highest numbers of people dying from it.”
“This study is the first large-scale clinical trial to understand the scope of penicillin usage in RHD treatment.”
“This is a very well done, very interesting study… Rheumatic heart disease is still a big issue worldwide.”
“Penicillin, a widely available and affordable antibiotic, may be one key to turning the tide on the deadly impacts of rheumatic heart disease (RHD) for children in developing nations. This according to the new findings of a large-scale, randomized controlled trial completed in Uganda and published in the New England Journal of Medicine.”
"It's really a disease of poverty," Craig Sable said. "Throughout sub-Saharan Africa, the disease is highly endemic, as it is in some parts of Asia and the poorer parts of India. People aren't paying attention to RHD because it is mostly happening in the poorest areas in Africa and other developing countries.”
“Many of these children are severely limited. They have swelling in their abdomen, they have extra fluid in the their lungs, they have trouble breathing; many of them can’t go to school,” said Sable, who partners with the Uganda Heart Institute for the surgeries.”
“An American cardiologist has taken it upon himself to see that Ugandan children get the treatment they need. VOA's Mike Richman has more on this doctor with a big heart.”
“One of the greatest joys in my life is to witness the transition of a child whose lips are dark blue from lack of oxygen and can’t walk across a room who then sends me a picture looking like all the other children playing soccer just a few short months after surgery.”